MacroCure
Petah Tiqva
About MacroCure
MacroCure is a biotechnology company focused on the development and commercialization of advanced cell therapy products. The company's first focus of interest is in the arena of wound care. The technology employs activated white blood cells obtained from young adults healthy donor blood. The activated cells provide the natural environment for wound healing, and ensure that necessary cell activities and factor secretions are maintained as required for wound healing. This novel concept is the first of its kind in the field of wound therapy.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Total funding: $48.0M
- Funding stage: M&A
- Last round: Series A (May 2012)
- Ticker: nasdaq:MCUR
- Website: macrocure.com
- Phone: +972 3-923-5556
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/macrocure-2171120 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.